Long-acting drugs market seen rising to US$ 13.3 billion by 2033

Persistence Market Research projects 8.9% CAGR from 2026, with chronic disease demand, microsphere-based delivery systems, and oral GLP-1 innovation supporting growth.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.